Before the advent of direct molecular gene analysis the diagnosis of Alport syndrome was operationally based on three of the four classical clinical criteria. Recently, mutations have been identified in the COL4A5 gene, which is involved in X-linked Alport syndrome. Here we describe two de-novo mutations in two unrelated children, a male and a female, both with early onset of the nephropathy, but with only one of the diagnostic criteria, i.e. electronmicroscopy alterations. Because of the significant estimated proportion of de-novo mutations this diagnosis should be considered in children with early signs of nephropathy, even without a suggestive family history or clinical picture (ocular or audiologic abnormalities). In the future the diagnosis of Alport syndrome will probably be made on the basis of both clinical findings and molecular analysis. Now Alport syndrome is clearly underdiagnosed.

Massella, L., Rizzoni, G., DE BLASIS, R., Barsotti, P., Faraggiana, T., Renieri, A., et al. (1994). De-novo COL4A5 gene mutations in Alport's syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION, 9(10), 1408-1411 [10.1093/oxfordjournals.ndt.a092664].

De-novo COL4A5 gene mutations in Alport's syndrome

RENIERI A.;
1994-01-01

Abstract

Before the advent of direct molecular gene analysis the diagnosis of Alport syndrome was operationally based on three of the four classical clinical criteria. Recently, mutations have been identified in the COL4A5 gene, which is involved in X-linked Alport syndrome. Here we describe two de-novo mutations in two unrelated children, a male and a female, both with early onset of the nephropathy, but with only one of the diagnostic criteria, i.e. electronmicroscopy alterations. Because of the significant estimated proportion of de-novo mutations this diagnosis should be considered in children with early signs of nephropathy, even without a suggestive family history or clinical picture (ocular or audiologic abnormalities). In the future the diagnosis of Alport syndrome will probably be made on the basis of both clinical findings and molecular analysis. Now Alport syndrome is clearly underdiagnosed.
1994
Massella, L., Rizzoni, G., DE BLASIS, R., Barsotti, P., Faraggiana, T., Renieri, A., et al. (1994). De-novo COL4A5 gene mutations in Alport's syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION, 9(10), 1408-1411 [10.1093/oxfordjournals.ndt.a092664].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/7262
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo